CYP19A1 and breast cancer: The present mouse model, to our knowledge, is the first to depict a typical breast cancer patient using an ovariectomy (post-menopausal woman), an orthotopic, syngeneic, ER+ mammary tumor, tumor resection, chemotherapy, and then aromatase inhibitor treatment.